Patrik Eriksson
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Patrik Eriksson
Envista Holdings Corp reported in an 8-K filed December 14, 2023 that Patrik Eriksson was terminated as SVP and President, Nobel Biocare, effective December 31, 2023. The proxy statement of Envista Holdings Corp reports total compensation of $1,601,606 for Patrik Eriksson in fiscal 2023, including a base salary of $550,000. Disclosed compensation is on record for 6 fiscal years.
“On December 11, 2023, Envista Holdings Corporation (the "Company") and Patrik Eriksson, the Company's SVP and President, Nobel Biocare, mutually agreed that Mr. Eriksson's employment will terminate effective December 31, 2023.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Envista Holdings Corp (NVST)
Proxy statement
Start not stated–2023-12-31
Company network
Recorded roles and call appearances connecting this person to public companies.
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2023 | Envista Holdings Corp (NVST) | SVP and President of Nobel Biocare, until December 31, 2023 | $550,000 | $1,601,606 |
| 2022 | Envista Holdings Corp (NVST) | SVP and President of Nobel Biocare, until December 31, 2023 | $550,000 | $1,684,768 |
| 2021 | Envista Holdings Corp (NVST) | SVP and President of Nobel Biocare, until December 31, 2023 | $550,000 | $2,019,011 |
| 2020 | Envista Holdings Corp (NVST) | SVP and President of Nobel Biocare | $519,327 | $1,796,915 |
| 2019 | Envista Holdings Corp (NVST) | SVP and President of Nobel Biocare | $486,677 | $2,331,345 |
| 2018 | Envista Holdings Corp (NVST) | SVP and President of Nobel Biocare | $444,206 | $1,453,001 |
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.